Krishna Institute Of Medical Science (KIMS) (NSE: KIMS, BSE: 543308) is a Secunderabad, Telangana-based company in the Hospitals and Healthcare Centers industry. With a market capitalisation of ₹29,056 Cr, it ranks #292 by market cap among the 6,197 Indian listed companies on FinBizNet, and #8 of 46 in Hospitals and Healthcare Centers. At ₹770.00 (as of 19 Nov 2026), the share price is 10.3% below its 52-week high of ₹858.00 and 33.7% above its 52-week low of ₹575.80. The share price is up 13.5% over one year and down 2.4% over three months.
| Current Price | ₹770.00 |
|---|---|
| Market Cap | ₹29,056 Cr |
| NSE Symbol | KIMS |
| BSE Code | 543308 |
| Sector | Health Care > Health Care Equipment and Services > Health Care Providers and Services |
| Sub-Industry | Health Care Facilities > Hospitals and Healthcare Centers |
| P/E Ratio | 120.6 |
| Return on Equity | 9.72% |
| Return on Assets | 4.83% |
| 52-Week Range | ₹575.80 – ₹858.00 |
| 1-Year Price Change | +13.5% |
| 3-Month Price Change | -2.4% |
| Beta (1Y) | 0.6 |
| Headquarters | Secunderabad, Telangana |
| Website | www.kimshospitals.com |
| Revenue | ₹1,344 Cr |
|---|---|
| Net Profit | ₹75 Cr |
| Net Margin | 5.5% |
| EPS (Basic) | ₹1.79 |
| Basis | consolidated |
Figures in ₹ crore, parsed from the company's exchange filing (XBRL).
Krishna Institute Of Medical Science (KIMS) reported revenue of ₹1,344 Cr in Q2 FY27, up 39.9% from ₹961 Cr in Q2 FY26 and up 14.0% from ₹1,180 Cr in Q1 FY27. It posted a net profit of ₹75 Cr for the quarter, against a net profit of ₹72 Cr in Q2 FY26 (up 3.6%). Across the 7 quarters from Q4 FY25 to Q2 FY27, quarterly revenue ranged from ₹797 Cr (Q4 FY25) to ₹1,344 Cr (Q2 FY27). The company was profitable in each of these 7 quarters.
| Quarter | Revenue | Net Profit | Net Margin |
|---|---|---|---|
| Q2 FY27 | ₹1,344 Cr | ₹75 Cr | 5.5% |
| Q1 FY27 | ₹1,180 Cr | ₹37 Cr | 3.2% |
| Q4 FY26 | ₹1,075 Cr | ₹33 Cr | 3.1% |
| Q3 FY26 | ₹998 Cr | ₹52 Cr | 5.2% |
| Q2 FY26 | ₹961 Cr | ₹72 Cr | 7.5% |
| Q1 FY26 | ₹872 Cr | ₹85 Cr | 9.8% |
| Q4 FY25 | ₹797 Cr | ₹106 Cr | 13.3% |
Consolidated figures (₹ crore, XBRL filings).
Promoters held 32.66% of Krishna Institute Of Medical Science (KIMS)'s shares as of Sept 2026, against 34.11% in Sept 2025 (−1.45 percentage points). Delivery averaged 58.7% of traded volume across 18 NSE sessions (26 Oct 2026 – 19 Nov 2026).
Krishna Institute of Medical Sciences Limited provides medical and health care services under the KIMS Hospitals brand in India. The company offers neurology, neurosurgery, psychiatry, and neuro rehabilitation; cardiology, cardiac and vascular surgery, heart transplant, and cardio rehabilitation; and pulmonology, interventional pulmonology, thoracic surgery, and lung transplant. It also provides medical and surgical gastroenterology, hepatobiliary pancreatic surgery, liver transplant, and bariatric surgery; ear, nose, throat, and head and neck surgery; and nephrology, urology, andrology, renal transplant, gynecology, urogynecology, IVF and art, fetal medicine, and obstetrics. In addition, the company offers orthopedics, arthroscopic and spine surgery, and ortho rehabilitation; medical surgical and radiation, and BMT and hematology; ophthalmology; dermatology, cosmetology, and plastic and reconstructive surgery; and clinical infectious diseases. Further, it provides imaging and interven
1. Medical and Healthcare Services-This segment provides medical and healthcare services. 2. Electricity Sales-0 3. Un-Allocable Corporate Assets-0
1. Medical and Healthcare Services-100%
| Company | Market Cap | P/E | ROE | Latest Qtr Revenue | 1Y Change |
|---|---|---|---|---|---|
| Apollo Hospitals Enterprise Limited | ₹1,23,712 Cr | 63 | 21.50% | ₹7,615 Cr | +17.4% |
| Max Healthcare Institute Ltd | ₹91,978 Cr | 63.9 | 14.33% | ₹2,569 Cr | -5.2% |
| Manipal Health Enterprises Ltd | ₹89,110 Cr | 88.4 | — | ₹3,399 Cr | — |
| Aster Dm Healthcare Limited (Asterdm) | ₹63,041 Cr | 97.6 | 10.07% | ₹2,829 Cr | +10.0% |
| Fortis Healthcare Ltd. | ₹58,283 Cr | 55.1 | 11.01% | ₹2,735 Cr | -15.0% |
| Global Health Ltd (Medanta) | ₹38,422 Cr | 69.7 | 15.03% | ₹1,469 Cr | +22.9% |
| Narayana Hrudayalaya Limited | ₹37,907 Cr | 46.2 | 19.85% | ₹2,844 Cr | +5.4% |
| Krishna Institute Of Medical Science (KIMS) | ₹29,056 Cr | 120.6 | 9.72% | ₹1,344 Cr | +13.5% |
| Dr. Agarwal's Health Care Limited | ₹17,568 Cr | 131.9 | 8.31% | ₹655 Cr | +7.6% |
Listed by market capitalisation. Ratios are shown for context only.
Krishna Institute Of Medical Science (KIMS) is trading at ₹770.00, with a market capitalisation of ₹29,056 Cr.
Krishna Institute Of Medical Science (KIMS) operates in the Health Care > Health Care Equipment and Services > Health Care Providers and Services space (Health Care Facilities > Hospitals and Healthcare Centers).
Krishna Institute Of Medical Science (KIMS) has a P/E of 120.6 and a return on equity of 9.72%.
Krishna Institute Of Medical Science (KIMS) is listed on the NSE under the symbol KIMS and on the BSE under the scrip code 543308.
Krishna Institute Of Medical Science (KIMS)'s share price is up 13.5% over one year and down 2.4% over three months. Its 52-week range is ₹575.80 to ₹858.00.
In Q2 FY27, Krishna Institute Of Medical Science (KIMS) reported revenue of ₹1,344 Cr and net profit of ₹75 Cr, with basic EPS of ₹1.79 (consolidated, parsed from the company's exchange filing).
Krishna Institute Of Medical Science (KIMS) reported revenue of ₹1,344 Cr in Q2 FY27, up 39.9% from ₹961 Cr in Q2 FY26 and up 14.0% from ₹1,180 Cr in Q1 FY27.
Promoters held 32.66% of Krishna Institute Of Medical Science (KIMS)'s shares as of Sept 2026, against 34.11% in Sept 2025 (−1.45 percentage points).
Data as of 19 Nov 2026. Descriptive market data only — not investment advice.